advertisement
Xu L 16
Showing records 1 to 16 | Display all abstracts from Xu L72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Xu L
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Chen S
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Zhang Y
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Lv J
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Guo R
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Fan S; Zhang H
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Shen W
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Xie L
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Qi Y; Wang Q
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Xu L
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Guo Z
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Jiang B; Yuan H
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Qi C; Yin H
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Liang Y; Li S
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Wang J
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Chen P; Zhang X; Wang N;
Trials 2017; 18: 130
